Tenax Therapeutics, Inc.
TENX
$6.00
-$0.04-0.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 0.28% | 109.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.00% | 55.43% | |||
| Operating Income | -4.00% | -55.43% | |||
| Income Before Tax | -4.22% | -66.08% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.22% | -66.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.22% | -66.08% | |||
| EBIT | -4.00% | -55.43% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -819.05% | -60.19% | |||
| Normalized Basic EPS | -819.12% | -60.18% | |||
| EPS Diluted | -819.05% | -60.19% | |||
| Normalized Diluted EPS | -819.12% | -60.18% | |||
| Average Basic Shares Outstanding | -88.66% | 3.66% | |||
| Average Diluted Shares Outstanding | -88.66% | 3.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||